The strategic research program I&I aims for a national and international leading role in obtaining and disseminating knowledge and innovations in the field of inflammatory and infectious diseases and immune-mediated therapy. We aim to improve treatment in patients with difficult-to-manage infections, immune diseases or cancer. Our doctors and researchers closely collaborate to deliver high-quality care and cutting edge research, where possible together with patients. We ensure our knowledge and expertise by training talented people to become the future generation of experts. Strategic program I&I is organized in four connected research themes. Each theme has distinct research lines, and clinicians, researchers and research groups are often active in more than one theme. The research themes are: preventing antimicrobial resistance; preventing inflammation; elucidating host-pathogen interactions; developing immune-mediated therapy and prevention.